Document Detail


Effects of long-term optimization and short-term deterioration of glycemic control on glucose counterregulation in type I diabetes mellitus.
MedLine Citation:
PMID:  6368295     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
To assess the effects of glycemic control on glucose counterregulation, rates of plasma glucose recovery from hypoglycemia and counterregulatory hormonal responses were studied in 18 C-peptide-negative patients with insulin-dependent diabetes mellitus (IDDM) before and after either improvement, no change, or deterioration in glycemic control. Hypoglycemia was induced by an i.v. insulin infusion (30 mU/m2 X min for 1 h) after maintenance of euglycemia overnight with i.v. insulin. In 13 patients with long duration of IDDM (9 +/- 0.5 yr, mean +/- SEM) and initially poor glycemic control (mean diurnal blood glucose, MBG 199 +/- 8 mg/dl, ketoamine-HbA1 12.4 +/- 0.2%; nondiabetic subjects 104 +/- 4 mg/dl and 6.8 +/- 0.09%, respectively), rates of plasma glucose recovery from hypoglycemia (0.30 +/- 0.01 versus 0.60 +/- 0.01 mg/dl X min in nondiabetic subjects, P less than 0.001) and plasma glucagon (AUC 0.56 +/- 0.09 versus 6.3 +/- 0.50 ng/ml X 150 min in nondiabetic subjects, P less than 0.01) and epinephrine (AUC 16.9 +/- 0.2 versus 25.7 +/- 0.2 ng/ml X 150 min in nondiabetic subjects, P less than 0.001) responses to hypoglycemia were impaired. Intensive therapy (three daily injections of insulin) instituted in 7 out of 13 IDDM patients for up to 9 mo improved MBG (124 +/- 6 mg/dl, P less than 0.01) and ketoamine-HbA1 (7.9 +/- 0.02%, P less than 0.01) but not rates of plasma glucose recovery (0.31 +/- 0.01 mg/dl X min) and plasma glucagon (AUC 0.69 +/- 0.07 ng/ml X 150 min) and epinephrine (AUC 14.9 +/- 0.17 ng/ml X 150 min) responses.(ABSTRACT TRUNCATED AT 250 WORDS)
Authors:
G Bolli; P De Feo; S De Cosmo; G Perriello; G Angeletti; M R Ventura; F Santeusanio; P Brunetti; J E Gerich
Related Documents :
428685 - Use of a glucose controlled insulin infusion system (artificial beta cell) to control d...
18495285 - Dose-dependent improvement in glycemia with once-daily liraglutide without hypoglycemia...
15919485 - Conversion from tacrolimus to cyclosporin is associated with a significant improvement ...
17996535 - Successive determination of urinary protein and glucose using spectrophotometric sequen...
8804545 - Diabetic ketoacidosis (dka): treatment guidelines.
1382525 - Elements in hair and nails of urban residents of new delhi. chd, hypertensive, and diab...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Diabetes     Volume:  33     ISSN:  0012-1797     ISO Abbreviation:  Diabetes     Publication Date:  1984 Apr 
Date Detail:
Created Date:  1984-05-14     Completed Date:  1984-05-14     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  0372763     Medline TA:  Diabetes     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  394-400     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Blood Glucose / analysis
Diabetes Mellitus, Type 1 / metabolism,  physiopathology*
Epinephrine / blood
Female
Glucagon / blood
Glucose / metabolism,  physiology*
Humans
Hypoglycemia / physiopathology
Insulin / physiology
Male
Grant Support
ID/Acronym/Agency:
AM-20411/AM/NIADDK NIH HHS
Chemical
Reg. No./Substance:
0/Blood Glucose; 11061-68-0/Insulin; 50-99-7/Glucose; 51-43-4/Epinephrine; 9007-92-5/Glucagon

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Glucose-dependent insulinotropic polypeptide augmentation of insulin. Physiology or pharmacology?
Next Document:  Clinical time-course and characteristics of islet cell cytoplasmatic antibodies in childhood diabete...